Material and method: This study analyzed 130 cases diagnosed GISTs with CD117 (+) from 01 - 2005 to 04 - 2011Results: The tumors were located in the stomach (51.6%), in small intestine (32.3%), in colorectum (5.4%), and extra-GI tract (10.7%).